Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × veliparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1

Interventions

Rituximab 88 Cyclophosphamide 82 Prednisone 48 Doxorubicin 42 Lenalidomide 39 Vincristine 35 polatuzumab vedotin 28 Magnetic Resonance Spectroscopy 27 Gemcitabine 26 Etoposide 26 fludarabine 25 Specimen Handling 24 CT-P10 20 Biopsy 20 Oxaliplatin 19 glofitamab 16 zanubrutinib 15 ibrutinib 15 tafasitamab 14 obinutuzumab 14 venetoclax 12 fludarabine phosphate 12 axicabtagene ciloleucel 12 Immunotherapy, Adoptive 12 Ifosfamide 12 pembrolizumab 10 deltacortene 10 acalabrutinib 10 Prednisolone 10 Leukapheresis 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡